Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee

Collins, P., Liesner, R., Makris, M. orcid.org/0000-0001-7622-7939 et al. (7 more authors) (2018) Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee. Haemophilia, 24 (3). pp. 344-347. ISSN 1351-8216

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 John Wiley & Sons Ltd. This is an author produced version of a paper subsequently published in Haemophilia. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: activated prothrombin complex concentrate; emicizumab; haemophilia; inhibitor; thrombosis; thrombotic angiopathy
Dates:
  • Accepted: 19 March 2018
  • Published (online): 1 June 2018
  • Published: 1 June 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 08 May 2018 13:01
Last Modified: 23 Nov 2020 14:37
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1111/hae.13495

Export

Statistics